At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 49 enrolled
Drug / intervention
LY900014 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized, Double-Blind, Crossover Comparison Evaluating Compatibility and Safety of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Patients With Type 1 Diabetes (PRONTO-Pump)
In Brief
A Phase 3 clinical trial evaluating LY900014 and Insulin lispro for Diabetes Type 1. Completed, enrolled 49 participants across 5 sites in 2 countries.
Detailed Summary
The purpose of this study is to evaluate the compatibility and safety of LY900014 and insulin lispro with an external continuous subcutaneous insulin infusion system in adult participants with type 1 diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Type 1
CountriesSpain, United States
Collaborators--
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartFeb 2018
Primary CompletionSep 2018
TodayJul 2026
First PostedFeb 14, 2018
Enrollment StartFeb 21, 2018
Primary CompletionSep 4, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.4 years ago
Interventions
LY900014drug
Administered by CSII
Insulin lisprodrug
Administered by CSII